[Form 4] Insulet Corporation Insider Trading Activity

Rhea-AI Filing Summary

Insulet Corporation (PODD) Form 4 filing: The reporting person, Prem Singh (SVP, Global Operations), sold 687 shares of Insulet common stock on 09/08/2025 at a weighted average sale price of $347.49 per share (sales ranged from $347.35 to $347.51). After the reported sale, Mr. Singh beneficially owned 3,456 shares, held directly. The sale was reported by an attorney-in-fact on behalf of the reporting person and the filer offers to provide breakouts of shares sold at each price upon request.

Positive

• None.

Negative

• Officer sale: Reporting person sold 687 shares, reducing direct beneficial ownership to 3,456 shares.
• Sale value approximate: Sale proceeds based on weighted average price amount to about $238,726 (687 shares x $347.49).

Insights

Securities Analyst

TL;DR: An officer sold a small block of shares; transaction appears routine and not materially large relative to company-level metrics provided.

The Form 4 discloses a direct sale of 687 shares by Prem Singh at a weighted average price of $347.49, leaving 3,456 shares beneficially owned. The filing contains no indication of a directive plan or other special circumstances. For investors, this is a clear, short disclosure of an insider sale; without additional context (e.g., total outstanding shares or recent trading patterns) the sale alone does not provide material evidence of company performance.

Corporate Governance Expert

TL;DR: Disclosure is complete for the reported transaction and includes the price range; signature is by attorney-in-fact.

The Form 4 includes the required details: reporting person, relationship (SVP, Global Operations), transaction date, number of shares sold, weighted average price and remaining beneficial ownership. The explanatory note states the price range and offers to provide further breakout data to SEC staff or stakeholders, which strengthens transparency. No additional governance red flags appear in the filing text provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singh Prem

(Last) (First) (Middle)

C/O INSULET CORPORATION

100 NAGOG PARK

(Street)

ACTON MA 01720

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Global Operations

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2025		S		687	D	$347.49(1)	3,456	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $347.35 to $347.51. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

	/s/ Patricia K. Dolan, attorney-in-fact	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Prem Singh report on Form 4 for PODD?

The filing reports that Prem Singh sold 687 shares of Insulet (PODD) on 09/08/2025 at a weighted average price of $347.49 per share.

How many Insulet shares does the reporting person own after the sale?

After the reported transaction, the reporting person beneficially owns 3,456 shares of Insulet common stock.

What price range did the shares sell for in the reported transaction?

The shares were sold at varying prices in the range of $347.35 to $347.51; the weighted average sale price reported is $347.49.

Who signed the Form 4 for the reporting person?

The Form 4 was signed on behalf of the reporting person by /s/ Patricia K. Dolan, attorney-in-fact on 09/09/2025.

Does the filing indicate the sale was made under a trading plan?

The Form 4 does not indicate that the transaction was made pursuant to a Rule 10b5-1 plan; no plan box is checked in the provided text.